US Pfizer offers a USD117b takeover for AstraZeneca


(MENAFN) Pfizer Inc., the US-based pharmaceutical firm, announced that it is currently preparing a takeover attempt over the British rival AstraZeneca Plc, QNA reported. A bid of USD117 billion is the final offer, Pfizer said, after many previous offers had been rejected by AstraZeneca management, one of which was a USD106 billion offer. German News Agency (DPA) reported Pfizer chief executive as saying "we have tried repeatedly to engage in a constructive process with AstraZeneca."


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.